MCRB Seres Therapeutics
- 0.749
- -0.361-32.49%
- 0.750
- +0.001+0.09%
Seres Therapeutics News
Seres Therapeutics | 10-Q: Quarterly report
Seres Therapeutics | 8-K: SERES THERAPEUTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES
Seres Therapeutics | 8-K: Current report
Seres Therapeutics | 8-K: Current report
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dere Willard H
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fraser Claire
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Biondi Paul
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kender Richard N
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Graves Kurt
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ausiello Dennis A
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Berenson Stephen
Seres Therapeutics | 8-K: Current report
Seres Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.5%)
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Thorell Marella
Seres Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Thorell Marella
Seres Therapeutics | DEF 14A: Definitive information statements
Seres Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Seres Therapeutics | 10-K: Annual report
Seres Therapeutics | 8-K: Current report
Seres Therapeutics | 8-K: Current report
Analysis
Price Target
No Data
